We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Sensus Healthcare, Inc. (SRTS) Stock Slides as Market Rises: Facts to Know Before You Trade
Read MoreHide Full Article
Sensus Healthcare, Inc. (SRTS - Free Report) ended the recent trading session at $5.48, demonstrating a -0.54% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 0.26%. Elsewhere, the Dow saw an upswing of 0.18%, while the tech-heavy Nasdaq appreciated by 0.35%.
Heading into today, shares of the company had gained 4.16% over the past month, outpacing the Medical sector's gain of 3.06% and the S&P 500's gain of 3.25% in that time.
Analysts and investors alike will be keeping a close eye on the performance of Sensus Healthcare, Inc. in its upcoming earnings disclosure. The company is expected to report EPS of $0.02, up 200% from the prior-year quarter. At the same time, our most recent consensus estimate is projecting a revenue of $6.87 million, reflecting a 51.66% rise from the equivalent quarter last year.
SRTS's full-year Zacks Consensus Estimates are calling for earnings of $0.29 per share and revenue of $34.28 million. These results would represent year-over-year changes of +866.67% and +40.46%, respectively.
Any recent changes to analyst estimates for Sensus Healthcare, Inc. should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Within the past 30 days, our consensus EPS projection has moved 262.5% higher. Sensus Healthcare, Inc. is currently a Zacks Rank #1 (Strong Buy).
Investors should also note Sensus Healthcare, Inc.'s current valuation metrics, including its Forward P/E ratio of 19. This denotes a discount relative to the industry's average Forward P/E of 25.49.
The Medical - Instruments industry is part of the Medical sector. This group has a Zacks Industry Rank of 159, putting it in the bottom 37% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Sensus Healthcare, Inc. (SRTS) Stock Slides as Market Rises: Facts to Know Before You Trade
Sensus Healthcare, Inc. (SRTS - Free Report) ended the recent trading session at $5.48, demonstrating a -0.54% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 0.26%. Elsewhere, the Dow saw an upswing of 0.18%, while the tech-heavy Nasdaq appreciated by 0.35%.
Heading into today, shares of the company had gained 4.16% over the past month, outpacing the Medical sector's gain of 3.06% and the S&P 500's gain of 3.25% in that time.
Analysts and investors alike will be keeping a close eye on the performance of Sensus Healthcare, Inc. in its upcoming earnings disclosure. The company is expected to report EPS of $0.02, up 200% from the prior-year quarter. At the same time, our most recent consensus estimate is projecting a revenue of $6.87 million, reflecting a 51.66% rise from the equivalent quarter last year.
SRTS's full-year Zacks Consensus Estimates are calling for earnings of $0.29 per share and revenue of $34.28 million. These results would represent year-over-year changes of +866.67% and +40.46%, respectively.
Any recent changes to analyst estimates for Sensus Healthcare, Inc. should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Within the past 30 days, our consensus EPS projection has moved 262.5% higher. Sensus Healthcare, Inc. is currently a Zacks Rank #1 (Strong Buy).
Investors should also note Sensus Healthcare, Inc.'s current valuation metrics, including its Forward P/E ratio of 19. This denotes a discount relative to the industry's average Forward P/E of 25.49.
The Medical - Instruments industry is part of the Medical sector. This group has a Zacks Industry Rank of 159, putting it in the bottom 37% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.